Showing results (51-60 of 232) with videos related to

Sort By:
Pageof 24
Leukemia Research|March 24, 2004
Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remissionMichael J Mauro, Brian J Druker, Richard T Maziarz
Toxicology and Applied Pharmacology|September 6, 2008
Reciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3Nicholette A Zeliadt, Laura J Mauro, Elizabeth V Wattenberg
Clinical Advances in Hematology & Oncology : H&O|January 26, 2010
Drug plasma monitoring in CML and GIST: A case-based discussionMerrill J Egorin, Michael J Mauro, Jonathan C Trent
The Journal of Biological Chemistry|May 26, 2004
Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic RasJanel K Warmka, Laura J Mauro, Elizabeth V Wattenberg
Nature Reviews. Clinical Oncology|June 6, 2025
Novel colorectal cancer screening methods - opportunities and challengesMelina A McCabe, Anthony J Mauro, Robert E Schoen
Annual Review of Medicine|January 31, 2002
Recent advancements in the treatment of chronic myelogenous leukemiaMichael E O'Dwyer, Michael J Mauro, Brian J Druker
Cytoskeleton (Hoboken, N.J.)|August 13, 2019
Relationship between dynamic instability of individual microtubules and flux of subunits into and out of polymerAva J Mauro, Erin M Jonasson, Holly V Goodson
Bio-Protocol|November 18, 2020
Using RNA Sequencing and Spike-in RNAs to Measure Intracellular Abundance of lncRNAs and mRNAsMegan D Schertzer, McKenzie M Murvin, J Mauro Calabrese
Pageof 24